The effect of 6-mercaptopurine (6-MP) and methotrexate (MTX) on passive delayed hypersensitivity reactions.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001772:Blood Cell Count; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000517:prevention & control*; D007112:Immunity, Maternally-Acquired; D015122:Mercaptopurine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D012882:Skin Tests; D014374:Tuberculin Test
D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D015122:Mercaptopurine; D008727:Methotrexate